Advertisement
Canada markets open in 7 hours 37 minutes

  • S&P/TSX

    22,346.76
    -121.40 (-0.54%)
     

  • S&P 500

    5,307.01
    -14.40 (-0.27%)
     

  • DOW

    39,671.04
    -201.95 (-0.51%)
     

  • CAD/USD

    0.7309
    +0.0003 (+0.04%)
     

  • CRUDE OIL

    76.92
    -0.65 (-0.84%)
     

  • Bitcoin CAD

    94,871.85
    -696.41 (-0.73%)
     

  • CMC Crypto 200

    1,510.90
    -15.52 (-1.02%)
     

  • GOLD FUTURES

    2,368.80
    -24.10 (-1.01%)
     

  • RUSSELL 2000

    2,081.71
    -16.65 (-0.79%)
     

  • 10-Yr Bond

    4.4340
    -4.4140 (-49.89%)
     

  • NASDAQ futures

    18,953.50
    +166.75 (+0.89%)
     

  • VOLATILITY

    12.29
    +0.43 (+3.63%)
     

  • FTSE

    8,370.33
    -46.12 (-0.55%)
     

  • NIKKEI 225

    39,044.78
    +427.68 (+1.11%)
     

  • CAD/EUR

    0.6748
    +0.0003 (+0.04%)
     

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks Equity Research
·2 min read

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors.

Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term.

Why This 1 Growth Stock Should Be On Your Watchlist

For growth investors, a company's financial strength, overall health, and future outlook take precedence, so they'll want to zero in on the Growth Style Score. This Score examines things like projected and historical earnings, sales, and cash flow to find stocks that will generate sustainable growth over time.

ADVERTISEMENT

HealthEquity (HQY)

Draper, UT-headquartered HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States.

HQY boasts a Growth Style Score of B and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating. Its bottom-line is projected to rise 28.9% year-over-year for 2025, while Wall Street anticipates its top line to improve by 15.5%.

Six analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.10 to $2.90 per share for 2025. HQY boasts an average earnings surprise of 17.4%.

Looking at cash flow, HealthEquity is expected to report cash flow growth of 27.9% this year; HQY has generated cash flow growth of 30.3% over the past three to five years.

HQY should be on investors' short lists because of its impressive growth fundamentals, a good Zacks Rank, and strong Growth and VGM Style Scores.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

HealthEquity, Inc. (HQY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research